EMP2 and non-small cell lung carcinoma: As shown in Figure 2B and Figure S5, ectopic EMP2 expression significantly inhibited NSCLC cell proliferation in comparison to mock control on day 1, 3, and 5 (p < 0.05, p < 0.01, or p < 0.001).